Medicare Enrolled
Dr. Michele Columbo, M.D.
Dermatology · Bryn Mawr, PA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Columbo from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Columbo?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Columbo
Dr. Michele Columbo is a dermatology specialist in Bryn Mawr, PA, with 21 years of NPI registration. Based on federal Medicare data, Dr. Columbo performed 13,983 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Columbo received a total of $195,447 from 44 pharmaceutical and/or device companies across 1016 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Columbo is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years of NPI registration
▲ Top 2% volume in PA
$195,447 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗13,983
Medicare services
Top 2% in PA for dermatology
Not available
Unique patients (not deduplicated)
$21
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Omalizumab injection (Xolair) for asthma/allergy | 6,421 | $26 | $115 |
| Allergy skin test A diagnostic test performed to identify specific allergies by applying or introducing allergenic extracts to the body. The procedure measures the patient's immune response to various potential allergens. |
3,586 | $3 | $8 |
| Allergy immunotherapy preparation A professional service involving the preparation and administration of one or more antigens. |
1,230 | $12 | $24 |
| Allergy injection therapy, multiple injections A professional service involving the administration of multiple allergen injections. |
701 | $9 | $25 |
| Allergy skin patch test A diagnostic test where small amounts of potential allergens are applied to the skin to identify substances that cause an allergic reaction. |
435 | $4 | $10 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
307 | $59 | $244 |
| Allergen injection administration Professional service for the administration of a single allergen injection. |
306 | $8 | $25 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
264 | $94 | $150 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
257 | $69 | $110 |
| Allergy test using drug or biological combination A diagnostic procedure to identify allergic reactions by testing a combination of methods using a specific drug or biological agent. |
108 | $17 | $30 |
| Skin allergy test A test where small amounts of potential allergens are injected into the skin to check for allergic reactions. |
96 | $7 | $15 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
93 | $129 | $215 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
73 | $20 | $65 |
| New patient office visit, complex (60-74 min) | 46 | $152 | $245 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
22 | $47 | $85 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
21 | $32 | $45 |
| Flu vaccine, quadrivalent A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection. |
17 | $76 | $123 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$195,447
Total received (2018-2024)
Avg $27,921/year across 7 years
Top 0% in PA for dermatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
44
Companies
1,016
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,809
2023
$3,445
2022
$2,363
2021
$5,769
2020
$5,678
2019
$54,191
2018
$120,192
Payments by company (2024)
AstraZeneca Pharmaceuticals LP
$624
GENZYME CORPORATION
$478
CSL Behring
$445
GlaxoSmithKline, LLC.
$310
PFIZER INC.
$267
BioCryst US Sales Co., LLC
$260
Grifols USA, LLC
$214
Takeda Pharmaceuticals U.S.A., Inc.
$175
ABBVIE INC.
$172
Alexion Pharmaceuticals, Inc.
$148
Optinose US, Inc.
$124
Amgen Inc.
$103
Novartis Pharmaceuticals Corporation
$97
Genentech USA, Inc.
$92
Regeneron Healthcare Solutions, Inc.
$77
Blueprint Medicines Corporation
$48
kaleo, Inc.
$46
Boehringer Ingelheim Pharmaceuticals, Inc.
$27
AltaThera Pharmaceuticals LLC
$27
Lilly USA, LLC
$26
Cycle Pharmaceuticals Inc
$25
Pharming Healthcare, Inc.
$23
Top 3 companies account for 40.6% of 2024 payments
All-time payments by company (2018-2024) ›
Shire North American Group Inc
$162,655
GlaxoSmithKline, LLC.
$5,828
Takeda Pharmaceuticals U.S.A., Inc.
$5,437
CSL Behring
$4,356
AstraZeneca Pharmaceuticals LP
$2,758
BioCryst Pharmaceuticals, Inc.
$2,277
BioCryst US Sales Co., LLC
$2,119
GENZYME CORPORATION
$1,551
Genentech USA, Inc.
$870
Regeneron Healthcare Solutions, Inc.
$869
Boehringer Ingelheim Pharmaceuticals, Inc.
$699
PFIZER INC.
$690
Pharming Healthcare, Inc.
$645
Grifols USA, LLC
$516
ALK-Abello, Inc
$465
Novartis Pharmaceuticals Corporation
$389
ABBVIE INC.
$369
OptiNose US, Inc.
$310
AbbVie Inc.
$291
Alexion Pharmaceuticals, Inc.
$269
Amgen Inc.
$267
Optinose US, Inc.
$265
kaleo, Inc.
$238
Bio Products Laboratory USA, Inc.
$211
Blueprint Medicines Corporation
$166
Kaleo, Inc.
$148
Octapharma USA, Inc.
$144
SANOFI-AVENTIS U.S. LLC
$125
LEO Pharma Inc.
$79
Teva Pharmaceuticals USA, Inc.
$52
Merck Sharp & Dohme Corporation
$49
ADMA BioManufacturing LLC
$48
Janssen Pharmaceuticals, Inc
$36
Incyte Corporation
$33
Circassia Pharmaceuticals Inc
$31
AltaThera Pharmaceuticals LLC
$27
Lilly USA, LLC
$26
Cycle Pharmaceuticals Inc
$25
Horizon Therapeutics plc
$21
Mylan Specialty L.P.
$21
Hikma Pharmaceuticals USA
$19
Philips Electronics North America Corporation
$18
Aytu BioPharma, Inc.
$18
Merck Sharp & Dohme LLC
$17
Top 3 companies account for 89.0% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · ACTIMMUNE · ADBRY · AIRSUPRA · AREXVY · ASMANEX · AUVI-Q · AYVAKIT · Aimovig · AirDuo Digihaler · Auvi-Q · BEVESPI AEROSPHERE · BREO · BREO ELLIPTA · BREZTRI · BREZTRI AEROSPHERE · CINRYZE · COMBIVENT RESPIMAT · CUTAQUIG · CUVITRU · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · Dymista · EBGLYSS · EUCRISA · FASENRA · GLASSIA · Gammaplex · Haegarda · Hizentra · JARDIANCE · Karbinal · NUCALA · OCTAGAM · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OPZELURA · ORLADEYO · Odactra · Orladeyo · PANZYGA · Prolastin-C · Prolastin-C Liquid · RINVOQ · RUCONEST · Ryaltris · SPIRIVA · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · STRENSIQ · SYMBICORT · Sajazir · Sotalol Hydrochloride · TAKHZYRO · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · XARELTO · XOLAIR · Xembify · Xhance · Xolair
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Dermatologists in nearby ZIP areas
178
County median income
$88,576
Nearest hospital to ZIP centroid (approximate)
BRYN MAWR HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Columbo is a mixed practice specialist, with above-average Medicare volume (top 2% in PA), with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Columbo experienced with omalizumab injection (xolair) for asthma/allergy?
Based on Medicare claims data, Dr. Columbo performed 6,421 omalizumab injection (xolair) for asthma/allergy services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Columbo receive payments from pharmaceutical companies?
Yes. Dr. Columbo received a total of $195,447 from 44 companies across 1,016 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Columbo's costs compare to other dermatologists in Bryn Mawr?
Dr. Columbo's average Medicare payment per service is $21. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Columbo) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Dermatology
Common procedures, typical costs, and what industry payments mean in dermatology.
Same specialty & city
Dermatologists in Bryn Mawr
Browse dermatologists in Bryn Mawr ranked by procedure volume and transparency data.
Highest volume
Top Dermatologists in PA
Dermatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Dermatologists in PA
Which PA dermatologists receive the most from drug and device companies.
By company
Shire North American Group Inc Payments to Doctors
See all physicians who received payments from Shire North American Group Inc.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
Takeda Pharmaceuticals U.S.A., Inc. Payments to Doctors
See all physicians who received payments from Takeda Pharmaceuticals U.S.A., Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology